Granted Patent
Utility
US 6,479,458 · App. 10/005,829
Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
Inventors:
Joseph S. Adorante, George R. Ehring, Kara L. Kopper
Patented Case
View Patent ↗
Granted: Nov 12, 2002
Filed: Nov 8, 2001
Inventors
Joseph S. Adorante
George R. Ehring
Kara L. Kopper
Assignee (at issue)
Allergan, Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.